Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for targeted cancer therapies. Its structure supports the design of molecules with high selectivity toward specific enzyme receptors. It is also employed in research settings to explore new heterocyclic compounds with potential biological activity. The compound's halogen and methyl group positioning enhances reactivity in cross-coupling reactions, making it valuable in medicinal chemistry for building complex drug-like molecules.